The Adjuvanted Recombinant Zoster Vaccine in Adults Aged ≥65 Years Previously Vaccinated With a Live-Attenuated Herpes Zoster Vaccine

BACKGROUND: Efficacy of the live-attenuated herpes zoster (HZ) vaccine (ZVL) wanes substantially over time. We evaluated immunogenicity and safety of the adjuvanted recombinant zoster vaccine (RZV) in previous ZVL recipients. METHODS: Adults aged ≥65 years who were previously vaccinated with ZVL ≥5...

Descripción completa

Detalles Bibliográficos
Autores principales: Dagnew, Alemnew F, Klein, Nicola P, Hervé, Caroline, Kalema, George, Di Paolo, Emmanuel, Peterson, James, Salaun, Bruno, Schuind, Anne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Major Articles and Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8514183/
https://www.ncbi.nlm.nih.gov/pubmed/32103273
http://dx.doi.org/10.1093/infdis/jiaa083

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8514183/
https://www.ncbi.nlm.nih.gov/pubmed/32103273
http://dx.doi.org/10.1093/infdis/jiaa083

Ejemplares similares